Decorin in Sub Scleral Trabeculectomy

• Status: Not yet recruiting
• Trial end date: 2022-01-01
• Target enrollment: 0
• Participant gender: All

Summary

This is a prospective, single-center, interventional, randomized controlled study comparing Decorin as antifibrotic agent in sub scleral trabeculectomy versus Mitomycin.

• Phase: Phase 1
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Cairo University
• Collaborator: University of Luebeck
• Treatments: Mitomycin; Mitomycins

Criteria

Inclusion Criteria:

• Primary Open Angle Glaucoma

Exclusion Criteria:

• Secondary Glaucoma, Closed angle glaucoma